← Back to VOLUME 13, ISSUE 10, OCTOBER 2026
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Gut–Muscle Axis in Age-Related Sarcopenia: Cause, Consequence, or Modifier?
Vishalakshi S and Premagowri B
👁 13 views📥 6 downloads
Abstract: Sarcopenia is an age-related, progressive loss of skeletal muscle mass, strength, and physical performance, increasing the risk of falls, hospitalization, loss of independence, and mortality among older adults. Recent research highlights the gut–muscle axis, through which gut microbiota communicate with skeletal muscle via metabolites and signalling pathways. This review examines animal mechanistic studies, intervention trials, and human observational research investigating the relationship between gut microbiota and sarcopenia in older adults. Key areas include short- chain fatty acids, bile acids, urolithin A, and tryptophan-derived metabolites as potential signalling molecules, alongside gut barrier integrity and low-grade inflammation as possible mediating pathways. Nutritional strategies, exercise, probiotics, prebiotics, synbiotics, postbiotics, and faecal microbiota transplantation are explored as potential interventions. Human observational studies generally indicate that individuals with sarcopenia exhibit reduced gut microbial diversity and fewer butyrate-producing taxa, although specific microbial profiles vary across studies. However, most observational evidence cannot establish causal relationships. Several intervention trials have reported measurable improvements in muscle strength or physical performance following supplementation with specific probiotic strains, Akkermansia-based postbiotics, prebiotics, and purified urolithin A. Nevertheless, the observed benefits are generally modest, follow-up periods are limited, and large-scale clinical trials remain lacking. Current evidence suggests that the gut microbiome may be a modifiable contributor to sarcopenia within the broader biological processes of ageing rather than an established independent cause. Future research should prioritize longitudinal studies, standardized microbiome assessment, mechanistic investigations, and adequately powered randomized controlled trials to establish causal relationships, identify effective interventions, and determine their long-term clinical relevance in preventing and managing sarcopenia among older adults.
Keywords: Sarcopenia; Gut–muscle axis; Gut microbiome; Older adults; Skeletal muscle health.
Keywords: Sarcopenia; Gut–muscle axis; Gut microbiome; Older adults; Skeletal muscle health.
How to Cite:
[1] Vishalakshi S and Premagowri B, “The Gut–Muscle Axis in Age-Related Sarcopenia: Cause, Consequence, or Modifier?,” International Advanced Research Journal in Science, Engineering and Technology (IARJSET), DOI: 10.17148/IARJSET.2026.131055
